Navigation LinksTop Biology NewsTop Medical NewsTop Biology TechnologyTop Medical Technology

Biology Technology

Veridiam Wins Workplace Excellence Crystal Award in Mid-Size Company Category

11/20/2009

0

GOOD
SAN DIEGO, Nov. 20 Veridiam (www.veridiam.com) won the prestigious Crystal Award in the mid-size company category at the 2009 Workplace Excellence Awards. The awards are sponsored by the San Diego Society for Human Resources Management and recognize innovative and exceptional human resources practices. Veridiam was one of nine winners, selected from more than 129... [Comments]

Dendreon Receives FDA Acknowledgement of Complete Response

11/20/2009

0

GOOD
SEATTLE, Nov. 20 Dendreon Corporation (Nasdaq: DNDN ) today announced that the U.S. Food and Drug Administration (FDA) provided written acknowledgement that the Company's amended Biologics License Application (BLA) for PROVENGE® (sipuleucel-T) is a complete response. The FDA has assigned a Prescription Drug User Fee Act (PDUFA) date of May 1, 2010, by... [Comments]

Novavax Prices Public Offering of Common Stock

11/20/2009

0

GOOD
ROCKVILLE, Md., Nov. 20 Novavax, Inc. (Nasdaq: NVAX ) today announced that it has priced an underwritten public offering of 6,800,000 shares of its common stock at a price to the public of $3.30 per share. The approximately $21 million of net proceeds, after deducting the underwriting discounts and commissions, will be used for preclinical studies and cli... [Comments]

Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation

11/20/2009

0

GOOD
STOCKHOLM, November 20 Karolinska Development AB todayannounced that the European Investment Fund (EIF) has entered into aco-investment agreement with the company. The co-investment fund will bemanaged by Karolinska Development and used to invest in the company'sportfolio of early-stage pharmaceutical and medical technology companies. EIFhas agreed to inve... [Comments]

Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group

11/20/2009

0

GOOD
SEATTLE, Nov. 20 Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that the Ninth Circuit Court of Appeals reversed a U.S. District Court order and ruled that CTI should be allowed to pursue all of its claims against The Lash Group, sending the case back to the District Court for trial. CTI filed a complaint against The Lash Group, CTI... [Comments]

Roller Compaction Process Optimization Using At-Line Particle Characterization

11/20/2009

0

GOOD
METTLER TOLEDO recently announced that a free webinar, “Roller Compactions Process Optimization Using At-Line Particle Characterization”, will be presented on December 2, 2009. In this webinar, the application of in situ particle characterization is demonstrated to map the design space and optimize a series of roller compaction runs while varying raw materi... [Comments]

Process Analytical Technology (PAT) in Green Chemistry and Green Engineering

11/20/2009

0

GOOD
METTLER TOLEDO recently announced that Dr. Dominique Hebrault will present a free webinar, “The Role of Process Analytical Technology (PAT) in Green Chemistry and Green Engineering” on December 1, 2009. (PRWEB) November 20, 2009 -- D... [Comments]Process Analytical Technology (PAT) in Green Chemistry and Green Engineering

Nanotube defects equal better energy and storage systems

11/19/2009

0

GOOD
 Most people would like to be able to charge their cell phones and other personal electronics quickly and not too often. A recent discovery made by UC San Diego engineers could lead to carbon nanotube-based supercapacitors that could do just this. In recent research, published in Applied... [Comments]Nanotube defects equal better energy and storage systems

DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel

11/19/2009

0

GOOD
COPENHAGEN, Nov. 19 Danish Prince Joachim inaugurated the DONG Energy and Inbicon cellulosic ethanol plant in Kalundborg, Denmark, on Wednesday, November 18. The facility is one of the world's first and largest 2nd generation ethanol demonstration biorefineries. Genencor's Accellerase enzymes are used in the plant's innovative process for converting straw to fuel. Genen... [Comments]

Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights

11/19/2009

0

GOOD
SEATTLE, Nov. 19 Omeros Corporation (Nasdaq: OMER ) today announced unaudited financial results for the third quarter ended September 30, 2009. For the three months ended September 30, 2009, Omeros reported a net loss of $3.9 million, or $1.34 per share, as compared to a net loss of $7.4 million, or $2.54 per share, for the same period in 2008. For the nine... [Comments]

American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor

11/19/2009

0

GOOD
BLAUVELT, N.Y., Nov. 19 Dr. Mate Hidvegi, inventor of Avemar fermented wheat germ extract, responds to a press release issued on November 17 by Biropharma Kft, discrediting the Hungarian company for making false and self-serving statements about its U.S. competitor American BioSciences. Dr. Hidvegi stated from his office in Budapest, Hungary: "The Biropha... [Comments]

Medicine Technology

Unilens Vision Reports Record First Quarter Earnings and Royalty Income

11/20/2009

0

GOOD
LARGO, Fla., Nov. 20 Unilens Vision Inc. (OTC Bulletin Board: UVICF; TSX Venture Exchange: UVI), which develops, licenses, manufactures, distributes and markets specialty contact lenses, today reported its operating results for the first quarter ended September 30, 2009 (FY2010). Net sales excluding royalty income, were $1,683,673 in the FY2010 first qu... [Comments]

Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal

11/20/2009

0

GOOD
CARY, N.C., Nov. 20 Cornerstone Therapeutics Inc. (Nasdaq: CRTX ), a specialty pharmaceutical company focused on acquiring, developing and commercializing significant products primarily for the respiratory and related markets, today reported that it had received a Warning Letter from the Food and Drug Administration ("FDA") alleging that its Deconsal CT che... [Comments]

National System Aims To Minimize Diversion of Cold and Allergy Medicine in Methamphetamine Production

11/20/2009

0

GOOD
LOUISVILLE, Ky., Nov. 20 The National Association of Drug Diversion Investigators (NADDI) today announced a new initiative in the war on methamphetamine. The National Precursor Log Exchange (NPLEx) is a multi-state electronic tracking program that enforces purchase limitations on over-the-counter (OTC) medicines containing pseudoephedrine in real-time at the point... [Comments]

Landauer, Inc. Sets Date and Time for Announcement of Fiscal Fourth Quarter and Full Year 2009 Results

11/20/2009

0

GOOD
GLENWOOD, Ill., Nov. 20 /PRNewswire-FirstCall/ -- Landauer, Inc. ( LDR) , will release financial results for the fiscal fourth quarter and full year of 2009 pre-market on Tuesday, December 1, 2009. The company will host a conference call for investors on Tuesday, December 1, 2009, at 2:00 p.m. Eastern Time. Investors may access the live call by dialing 877-941-9205 (within... [Comments]

Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost

11/20/2009

0

GOOD
NEW YORK, Nov. 20 Medco Health Solutions, Inc (NYSE: MHS ) is today contributing to a transformation in American healthcare through an advanced, wired pharmacy paradigm that is already delivering higher quality clinical care and fundamentally bending the cost curve downward -- making medicine smarter for the benefit of patients and payors alike. The... [Comments]

Pennsylvania Department of Health Begins Statewide H1N1 Vaccination Clinics Targeting Priority Populations; Some Appointments Still Available

11/20/2009

0

GOOD
HARRISBURG, Pa., Nov. 20 The Department of Health today began providing free H1N1 flu shots to members of priority groups that did not have previous access to the vaccine. A total of 18 clinics are being held statewide on Nov. 20-22. Friday's clinic hours are from 2 p.m. to 8 p.m. Hours on Saturday, Nov. 21, will be 8 a.m. to 2 p.m. On Sunday, Nov. 2... [Comments]

Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis

11/20/2009

0

GOOD
NEW YORK, Nov. 20 Reportlinker.com announces that a new market research report is available in its catalogue. Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis http://www.reportlinker.com/p0164309/Blood-Pressure-Monitoring--Measurement-Instruments---A-World-Market-Analysis.html#utm_source=prnewswire&utm_medium=pr... [Comments]

Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth

11/20/2009

0

GOOD
NEW YORK, Nov. 20 Reportlinker.com announces that a new market research report is available in its catalogue. Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth http://www.reportlinker.com/p0164657/Global-Self-Monitoring-Blood-Glucose-Market-(SMBG )-Increasing-Adoption-to-Drive-Growth.html#utm_source=prnewswire&... [Comments]

Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective

11/20/2009

0

GOOD
NEW YORK, Nov. 20 Reportlinker.com announces that a new market research report is available in its catalogue. Pipettes & Pipettors - A Global Market Perspective http://www.reportlinker.com/p0164373/Pipettes--Pipettors---A-Global-Market-Perspective.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire Pipettes and pipe... [Comments]

Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015

11/20/2009

0

GOOD
NEW YORK, Nov. 20 Reportlinker.com announces that a new market research report is available in its catalogue. India Medical Equipment Market Analysis and Forecasts to 2015 http://www.reportlinker.com/p0164658/India-Medical-Equipment-Market-Analysis-and-Forecasts-to-2015.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire... [Comments]

Reportlinker Adds Global Markets for Breast Biopsy Devices 2009

11/20/2009

0

GOOD
NEW YORK, Nov. 20 Reportlinker.com announces that a new market research report is available in its catalogue. Global Markets for Breast Biopsy Devices 2009 http://www.reportlinker.com/p0164741/Global-Markets-for-Breast-Biopsy-Devices-2009.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire The global markets for b... [Comments]

(Date:11/18/2009)...lif., Nov. 18 Marrone Bio Innovati...and commercialization of effective and environment...ed that it has been named an IC20 company by the I...rgest national angel investing group. ,, Compan... to rewarding results for all stakeholders, includ...
(Date:11/18/2009)... Imagine a polka-dotted postage stamp that can sn... changing colors. , As reported in the Sept. 13 ...uslick and his team at the University of Illinois ...detection of toxic industrial chemicals (TICs) tha...sualizing odors. This sensor array could be usefu...
(Date:11/18/2009)...er,s experience in data analysis combined with Bio... kits and curricula provide state-of-the-art s...TON, Ore., Nov. 18 Vernier Softwar...nce interfaces, sensors, and software and Bio-Rad ...nd distributor of life science research and clinic...
(Date:11/18/2009)... YORK, Nov. 18 Reportlinker.com an...able in its catalogue. ,, Biotechnology Reage.../www.reportlinker.com/p0164375/Biotechnology-Reage...prnewswire&utm_medium=pr&utm_campaign=prne...complex chemical compounds used in a range of biot...
Breaking Biology Technology:Marrone Bio Innovations Named an IC20 Company 2Opto-electronic nose sniffs out toxic gases 2Opto-electronic nose sniffs out toxic gases 3Vernier and Bio-Rad to Offer Enhanced Solutions for Biotechnology Education 2Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 2Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 3Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 4Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 5Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 6Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 7Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 8
...EC CITY, Feb. 12 /PRNewswire-FirstCall/ - AEterna ... biopharmaceutical company focused on,endocrine th...AEZS-108, a,luteinizing hormone-releasing hormone ... in its Phase 2 trial in gynaecological cancers fo...07. This open-label,non-comparative multi-center P...
...ad Clinical Program and Two Clinical Candidates Fe...aven,biotechnologies, inc., a privately held compa...oclonal antibody therapeutics (MAbs) for cancer,an...entation at the meeting,of American Association fo... 12-16, 2008., "We are pleased to have this oppor...
...CARLOS, Calif., Feb. 12 Nektar,Therapeutics (Nasd...ed to,complete its transition from a drug delivery...nt organization. The restructuring will,streamline... strengthen,decision-making and execution within t...nto a world-class drug development company,and the...
Other Biology Technology:AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers 2AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers 3AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers 4Raven biotechnologies to Provide Updates on Oncology Pipeline With Four AACR Presentations 2Raven biotechnologies to Provide Updates on Oncology Pipeline With Four AACR Presentations 3Nektar Announces Restructuring to Complete Its Transition to a Therapeutics Drug Development Organization 2Nektar Announces Restructuring to Complete Its Transition to a Therapeutics Drug Development Organization 3
(Date:11/20/2009)..., , NEW YORK, Nov. 20 R...ch report is available in its catalogue. ,, Gl...Increasing Adoption to Drive Growth ,, http:...ring-Blood-Glucose-Market-(SMBG )-Increasing-Adopt...;utm_medium=pr&utm_campaign=prnewswire ,, ...
(Date:11/20/2009)..., , NEW YORK, Nov. 20 ,...research report is available in its catalogue. ,... ,, http://www.reportlinker.com/p0164741/Glob..._source=prnewswire&utm_medium=pr&utm_campa...st biopsy devices includes the spring loaded core ...
(Date:11/20/2009)..., , NATICK, Mass. and LONDON, Nov. 20 /PRN...n (NYSE: BSX ) today announced that it has recei...dministration (FDA) and CE Mark approval to market... for the treatment of malignant esophageal strictu...th resectable or non-resectable esophageal cancer....
Breaking Medicine Technology:Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 2Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 3Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 4Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 5Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 6Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 7Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 8Reportlinker Adds Global Markets for Breast Biopsy Devices 2009 2Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 2Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 3Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 4Study details safe effective minimally invasive mitral valve repair 10133 1Study details safe effective minimally invasive mitral valve repair 10133 2Study details safe effective minimally invasive mitral valve repair 10133 3Improved Screening for Jaundice Can Protect Newborns 58406 1Improved Screening for Jaundice Can Protect Newborns 58406 2NovoCure Ltd announces closing of financing round 58401 1NovoCure Ltd announces closing of financing round 58401 2
...- On Wednesday,July 11, 2007, at 1:30 p.m. Pacifi...me members of Cell Therapeutics, Inc.,s (CTI),mana... today,s,announcement of the interim results of it...P-R, in which pixantrone is substituted for,doxoru...of patients,with aggressive non-Hodgkin,s lymphoma...
...importance in modern clinical laboratories in step...s from clinicians for rapid turnaround times, and ...nologists. Ultimately, the laboratories that imple...equipped to meet these modern demands. , ,With....g. sample processing robotics, decision managemen...
Other Medicine Technology:Cell Therapeutics, Inc. Management to Discuss Today's Announcement,of Interim Pixantrone Study Results 2Optimizing Quality Control Data Management 2Optimizing Quality Control Data Management 3Optimizing Quality Control Data Management 4Optimizing Quality Control Data Management 5